588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Icovamenib Acute Myeloid Leukemia	Biomea Fusion Inc.	P1	C (36)
Immunoglobulin G4, Anti-(Human Colony-Stimulating Factor 1 Receptor) (Human-Rattus Norvegicus Monoclonal Sndx-6352 .Gamma.4-Chain), Disulfide With Human-Rattus Norvegicus Monoclonal Sndx-6352 .Kappa.-Chain, Dimer Acute Myeloid Leukemia	Northside Hospital, Inc.	P1	C (36)
Indium In 111-Dota-Basiliximab Acute Myeloid Leukemia	City of Hope Medical Center	P1	C (36)
Indium In 111-Dota-Daratumumab Acute Myeloid Leukemia	City of Hope Medical Center	P1	C (36)
Jnj-75276617 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	C (36)
Lcar-Amdr Cells Product Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	C (36)
Levofloxacin Iv Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P1	C (36)
lp-108 Acute Myeloid Leukemia	Guangzhou Lupeng Pharmaceutical Company LTD.	P1	C (36)
lp-118 Acute Myeloid Leukemia	Newave Pharmaceutical Inc	P1	C (36)
Mgta-117 Acute Myeloid Leukemia	Magenta Therapeutics, Inc.	P1	C (36)
Mrx-2843 Acute Myeloid Leukemia	Meryx, Inc.	P1	C (36)
Navitoclax Acute Myeloid Leukemia	Medical College of Wisconsin	P1	C (36)
Orcagraft Acute Myeloid Leukemia	Orca Biosystems, Inc.	P1	C (36)
Orm-6151 Acute Myeloid Leukemia	Bristol-Myers Squibb	P1	C (36)
Partially Engineered T-Regulatory Cell Donor Graft Trgft-201 Acute Myeloid Leukemia	City of Hope Medical Center	P1	C (36)
Pasifolate Exatecan Acute Myeloid Leukemia	Elucida Oncology	P1	C (36)
Pemigatinib Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P1	C (36)
pep07 Acute Myeloid Leukemia	PharmaEngine	P1	C (36)
Prgn-3006 T Cells Acute Myeloid Leukemia	Precigen, Inc	P1	C (36)
q702 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1	C (36)
Rem-422 Acute Myeloid Leukemia	Remix Therapeutics	P1	C (36)
Rezatapopt Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1	C (36)
Romiplostim Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	P1	C (36)
RPT1G Acute Myeloid Leukemia	Remedy Plan, Inc.	P1	C (36)
Sc-Daric33 Acute Myeloid Leukemia	Seattle Children's Hospital	P1	C (36)
Sea-Cd70 Acute Myeloid Leukemia	Seagen, a wholly owned subsidiary of Pfizer	P1	C (36)
Sgr-2921 Acute Myeloid Leukemia	Schrödinger, Inc.	P1	C (36)
sl-172154 Acute Myeloid Leukemia	Shattuck Labs, Inc.	P1	C (36)
Sprx002 Acute Myeloid Leukemia	Arcellx, Inc.	P1	C (36)
Stx-0712 Acute Myeloid Leukemia	Solu Therapeutics, Inc	P1	C (36)
Succimer Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1	C (36)
taa05 cell Acute Myeloid Leukemia	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1	C (36)
Taa-Specific Ctls Acute Myeloid Leukemia	Baylor College of Medicine	P1	C (36)
Targeted Aml1-Eto Neoantigen Cytotoxic T Cells Acute Myeloid Leukemia	BGI, China	Early P1	C (36)
tqb2928 Acute Myeloid Leukemia	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P1	C (36)
Umbilical Cord Derived Mesenchymal Stem Cells Exosomes Acute Myeloid Leukemia	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1	C (36)
Unicar02-T Acute Myeloid Leukemia	AvenCell Therapeutics, Inc.	P1	C (36)
Universal Cll1 Car-T Cells Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1	C (36)
Vactosertib Acute Myeloid Leukemia	David Wald	P1	C (36)
vip943 Acute Myeloid Leukemia	Vincerx Pharma, Inc.	P1	C (36)
Wu-Cart-007 Acute Myeloid Leukemia	Washington University School of Medicine	P1	C (36)
Xmab18968 Acute Myeloid Leukemia	Ehab L Atallah	P1	C (36)
xs-04 Acute Myeloid Leukemia	NovaOnco Therapeutics Co., Ltd.	P1	C (36)
Yttrium Y 90 Basiliximab Acute Myeloid Leukemia	City of Hope Medical Center	P1	C (36)
ze 50-0134 Acute Myeloid Leukemia	Lomond Therapeutics Holdings, Inc.	P1	C (36)
Zoledronate Acute Myeloid Leukemia	University of Wisconsin, Madison	P1	C (36)
Gamma-Delta (??) T Cells Acute Myeloid Leukemia	H. Lee Moffitt Cancer Center and Research Institute	P1	C (34)
il-12 Acute Myeloid Leukemia	University Health Network, Toronto	P1	C (34)
CD117 CAR T-cells Acute Myeloid Leukemia	Zhejiang University	Early P1	C (33)
nkg2d car t-cells Acute Myeloid Leukemia	Zhejiang University	Early P1	C (33)

Showing 501 to 550 of 588 assets

PreviousPage 11 of 12Next